GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Issuance of Debt

Pharmaresearch Bio Co (XKRX:217950) Issuance of Debt : ₩10,000 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Issuance of Debt?

Pharmaresearch Bio Co's Issuance of Debt for the six months ended in Dec. 2024 was ₩10,000 Mil.

Pharmaresearch Bio Co's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₩10,000 Mil.


Pharmaresearch Bio Co Issuance of Debt Historical Data

The historical data trend for Pharmaresearch Bio Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Issuance of Debt Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial - 30,000.00 - - No Debt

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt Get a 7-Day Free Trial - 30,000.00 - - No Debt

Pharmaresearch Bio Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₩10,000 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines